Your browser doesn't support javascript.
loading
The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias.
Selvadurai, Louisa P; Perlman, Susan L; Ashizawa, Tetsuo; Wilmot, George R; Onyike, Chiadi U; Rosenthal, Liana S; Shakkottai, Vikram G; Paulson, Henry L; Subramony, Sub H; Bushara, Khalaf O; Kuo, Sheng-Han; Dietiker, Cameron; Geschwind, Michael D; Nelson, Alexandra B; Gomez, Christopher M; Opal, Puneet; Zesiewicz, Theresa A; Hawkins, Trevor; Yacoubian, Talene A; Nopoulos, Peggy C; Sha, Sharon J; Morrison, Peter E; Figueroa, Karla P; Pulst, Stefan M; Schmahmann, Jeremy D.
Afiliación
  • Selvadurai LP; Department of Neurology, Ataxia Center, Cognitive Behavioral Neurology Unit, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School, 100 Cambridge Street, Suite 2000, Boston, MA, 02114, USA.
  • Perlman SL; Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Ashizawa T; Department of Neurology, Houston Methodist Research Institute, Houston, TX, USA.
  • Wilmot GR; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Onyike CU; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Rosenthal LS; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Shakkottai VG; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Paulson HL; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Subramony SH; Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
  • Bushara KO; Department of Neurology, McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA.
  • Kuo SH; Department of Neurology, University of Minnesota, Minneapolis, MN, USA.
  • Dietiker C; Department of Neurology, Columbia University, New York, NY, USA.
  • Geschwind MD; Department of Neurology, University of California, San Francisco, CA, USA.
  • Nelson AB; Department of Neurology, University of California, San Francisco, CA, USA.
  • Gomez CM; Department of Neurology, University of California, San Francisco, CA, USA.
  • Opal P; Department of Neurology, University of Chicago, Chicago, IL, USA.
  • Zesiewicz TA; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Hawkins T; Department of Neurology, University of South Florida Ataxia Research Center, Tampa, FL, USA.
  • Yacoubian TA; Department of Neurology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
  • Nopoulos PC; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Sha SJ; Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
  • Morrison PE; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
  • Figueroa KP; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
  • Pulst SM; Department of Neurology, University of Utah, Salt Lake City, UT, USA.
  • Schmahmann JD; Department of Neurology, University of Utah, Salt Lake City, UT, USA.
Cerebellum ; 23(4): 1411-1425, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38165578
ABSTRACT
The Cerebellar Cognitive Affective/Schmahmann Syndrome (CCAS) manifests as impaired executive control, linguistic processing, visual spatial function, and affect regulation. The CCAS has been described in the spinocerebellar ataxias (SCAs), but its prevalence is unknown. We analyzed results of the CCAS/Schmahmann Scale (CCAS-S), developed to detect and quantify CCAS, in two natural history studies of 309 individuals Symptomatic for SCA1, SCA2, SCA3, SCA6, SCA7, or SCA8, 26 individuals Pre-symptomatic for SCA1 or SCA3, and 37 Controls. We compared total raw scores, domain scores, and total fail scores between Symptomatic, Pre-symptomatic, and Control cohorts, and between SCA types. We calculated scale sensitivity and selectivity based on CCAS category designation among Symptomatic individuals and Controls, and correlated CCAS-S performance against age and education, and in Symptomatic patients, against genetic repeat length, onset age, disease duration, motor ataxia, depression, and fatigue. Definite CCAS was identified in 46% of the Symptomatic group. False positive rate among Controls was 5.4%. Symptomatic individuals had poorer global CCAS-S performance than Controls, accounting for age and education. The domains of semantic fluency, phonemic fluency, and category switching that tap executive function and linguistic processing consistently separated Symptomatic individuals from Controls. CCAS-S scores correlated most closely with motor ataxia. Controls were similar to Pre-symptomatic individuals whose nearness to symptom onset was unknown. The use of the CCAS-S identifies a high CCAS prevalence in a large cohort of SCA patients, underscoring the utility of the scale and the notion that the CCAS is the third cornerstone of clinical ataxiology.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ataxias Espinocerebelosas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ataxias Espinocerebelosas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article